ym 264 has been researched along with methylprednisolone in 1 studies
| Studies (ym 264) | Trials (ym 264) | Recent Studies (post-2010) (ym 264) | Studies (methylprednisolone) | Trials (methylprednisolone) | Recent Studies (post-2010) (methylprednisolone) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 20,247 | 2,602 | 5,317 |
| Protein | Taxonomy | ym 264 (IC50) | methylprednisolone (IC50) |
|---|---|---|---|
| Glucocorticoid receptor | Homo sapiens (human) | 0.011 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.011 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horie, M; Mase, T; Nagaoka, H; Sakurai, Y; Tomioka, K; Yamada, T | 1 |
1 other study(ies) available for ym 264 and methylprednisolone
| Article | Year |
|---|---|
Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat.
Topics: Animals; Azepines; Disease Models, Animal; Glomerulonephritis, Membranous; Hypercholesterolemia; Male; Metabolic Clearance Rate; Methylprednisolone; Piperazines; Platelet Activating Factor; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Ticlopidine; Triazoles | 1991 |